TipRanks on MSN

Novo Nordisk’s Wegovy study in Korea: A potential game-changer for obesity treatment

Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled WEgovy Real ...
inews.co.uk on MSN

Wegovy on the NHS ends after 24 months – meaning weight gain or going private

A spokesperson for Novo Nordisk, the manufacturer of Wegovy, said: “Wegovy is indicated for weight management, including ...
New York Magazine

The Best Gifts You Can Buy at a Pharmacy

Let their fingers prune in a Dr. Teal’s–branded bubble bath, available in lavender; ginseng, ginger, and rhodiola rosea; eucalyptus and spearmint; and shea butter with almond oil. If they haven’t ...

European Regulator Backs Approval Of Novo Nordisk High-Dose Wegovy

EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in ...

NVO Down 42% Year to Date: Is This an Indication to Sell the Stock?

Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud ...

Doctors call for cigarette-style warning label on GLP-1 drugs like Ozempic due to this ‘very dangerous’ risk

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Novo’s High-Dose Wegovy Gets Green Light From EU Drug Panel

Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...